Head-scratchers seem to be the order of the day at the German switch committee’s next meeting on 26 January 2021.
Firstly, Germany’s Expert Committee for Prescription – an independent body that advises the country’s Ministry of Health, the BMG, on reclassifications – will consider the reverse-switch of tyrothricin for the...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?